PhoenixBio Co., Ltd. (6190.T)
JPY 335.0
(-1.76%)
JPY 335.0
(-1.76%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.71 Billion JPY | -19.24% |
| 2022 | 2.12 Billion JPY | 60.33% |
| 2021 | 1.32 Billion JPY | 30.71% |
| 2020 | 1.01 Billion JPY | -22.63% |
| 2019 | 1.31 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 449 Million JPY | 16.11% |
| 2023 Q2 | 442.59 Million JPY | 0.78% |
| 2023 Q4 | 386.69 Million JPY | -13.47% |
| 2023 Q3 | 446.87 Million JPY | 0.97% |
| 2023 FY | 1.71 Billion JPY | -19.24% |
| 2023 Q1 | 439.16 Million JPY | -5.3% |
| 2022 Q2 | 690.06 Million JPY | 0.0% |
| 2022 FY | 2.12 Billion JPY | 60.33% |
| 2022 Q4 | 463.75 Million JPY | -11.68% |
| 2022 Q3 | 525.11 Million JPY | -23.9% |
| 2021 FY | 1.32 Billion JPY | 30.71% |
| 2020 FY | 1.01 Billion JPY | -22.63% |
| 2019 FY | 1.31 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 4.77 Billion JPY | 64.04% |
| PRISM BioLab Co.,LTD | 112.92 Million JPY | -1418.978% |
| GNI Group Ltd. | 26.01 Billion JPY | 93.405% |
| Linical Co., Ltd. | 12.3 Billion JPY | 86.063% |
| Trans Genic Inc. | 13.08 Billion JPY | 86.889% |
| MEDINET Co., Ltd. | 661.54 Million JPY | -159.291% |
| Soiken Holdings Inc. | 5.15 Billion JPY | 66.747% |
| Cytori Cell Research Institute, Inc. | 1.56 Billion JPY | -9.929% |
| AnGes, Inc. | 152.98 Million JPY | -1021.235% |
| OncoTherapy Science, Inc. | 610.11 Million JPY | -181.146% |
| Nxera Pharma Co., Ltd. | 12.76 Billion JPY | 86.563% |
| Immuno-Biological Laboratories Co., Ltd. | 816.7 Million JPY | -110.03% |
| NanoCarrier Co., Ltd. | 135.5 Million JPY | -1165.845% |
| Carna Biosciences, Inc. | 1.62 Billion JPY | -5.5% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 428.36 Million JPY | -300.435% |
| RaQualia Pharma Inc. | 1.9 Billion JPY | 9.777% |
| Chiome Bioscience Inc. | 682.46 Million JPY | -151.342% |
| Kidswell Bio Corporation | 2.43 Billion JPY | 29.447% |
| PeptiDream Inc. | 28.71 Billion JPY | 94.026% |
| Oncolys BioPharma Inc. | 63.03 Million JPY | -2621.09% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | 121 Million JPY | -1317.621% |
| BrightPath Biotherapeutics Co., Ltd. | 72 Thousand JPY | -2382290.278% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 39.88 Million JPY | -4200.451% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 4.51 Billion JPY | 61.971% |
| FunPep Company Limited | 530 Thousand JPY | -323545.472% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -2376.998% |
| Stella Pharma Corporation | 269.49 Million JPY | -536.504% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | 316.81 Million JPY | -441.422% |
| Cuorips Inc. | 23.1 Million JPY | -7324.989% |
| K Pharma,Inc. | 1 Billion JPY | -71.532% |
| Takara Bio Inc. | 43.5 Billion JPY | 96.057% |
| ReproCELL Incorporated | 2.42 Billion JPY | 29.318% |
| StemCell Institute Inc. | 2.48 Billion JPY | 30.867% |
| Japan Tissue Engineering Co., Ltd. | 2.51 Billion JPY | 31.774% |
| CellSeed Inc. | 190.13 Million JPY | -802.164% |